Daniel C. Javitt - Publications

Affiliations: 
The Nathan S. Kline Institute, Orangeburg, NY, United States 
Area:
Cognitive Neuroscience and Schizophrenia

294 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any innacuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Medalia A, Saperstein AM, Qian M, Javitt DC. Impact of baseline early auditory processing on response to cognitive remediation for schizophrenia. Schizophrenia Research. PMID 30665714 DOI: 10.1016/j.schres.2019.01.012  0.52
2018 Dondé C, Silipo G, Dias EC, Javitt DC. Hierarchical deficits in auditory information processing in schizophrenia. Schizophrenia Research. PMID 30551982 DOI: 10.1016/j.schres.2018.12.001  0.84
2018 Martínez A, Gaspar PA, Hillyard SA, Andersen SK, Lopez-Calderon J, Corcoran CM, Javitt DC. Impaired Motion Processing in Schizophrenia and the Attenuated Psychosis Syndrome: Etiological and Clinical Implications. The American Journal of Psychiatry. appiajp201818010072. PMID 30278791 DOI: 10.1176/appi.ajp.2018.18010072  0.76
2018 Yuan A, Veeranna, Sershen H, Basavarajappa BS, Smiley JF, Hashim A, Bleiwas C, Berg M, Guifoyle DN, Subbanna S, Darji S, Kumar A, Rao MV, Wilson DA, Julien JP, ... Javitt DC, et al. Neurofilament light interaction with GluN1 modulates neurotransmission and schizophrenia-associated behaviors. Translational Psychiatry. 8: 167. PMID 30143609 DOI: 10.1038/s41398-018-0194-7  0.56
2018 Hoptman MJ, Parker EM, Nair-Collins S, Dias EC, Ross ME, DiCostanzo JN, Sehatpour P, Javitt DC. Sensory and cross-network contributions to response inhibition in patients with schizophrenia. Neuroimage. Clinical. 18: 31-39. PMID 29868440 DOI: 10.1016/j.nicl.2018.01.001  0.96
2018 Pobric G, Hulleman J, Lavidor M, Silipo G, Rohrig S, Dias E, Javitt DC. Seeing the World as it is: Mimicking Veridical Motion Perception in Schizophrenia Using Non-invasive Brain Stimulation in Healthy Participants. Brain Topography. PMID 29516204 DOI: 10.1007/s10548-018-0639-6  0.72
2018 Corcoran CM, Carrillo F, Fernández-Slezak D, Bedi G, Klim C, Javitt DC, Bearden CE, Cecchi GA. Prediction of psychosis across protocols and risk cohorts using automated language analysis. World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 17: 67-75. PMID 29352548 DOI: 10.1002/wps.20491  0.4
2017 Javitt DC, Carter CS, Krystal JH, Kantrowitz JT, Girgis RR, Kegeles LS, Ragland JD, Maddock RJ, Lesh TA, Tanase C, Corlett PR, Rothman DL, Mason G, Qiu M, Robinson J, et al. Utility of Imaging-Based Biomarkers for Glutamate-Targeted Drug Development in Psychotic Disorders: A Randomized Clinical Trial. Jama Psychiatry. PMID 29167877 DOI: 10.1001/jamapsychiatry.2017.3572  0.6
2017 Corcoran CM, Stoops A, Lee M, Martinez A, Sehatpour P, Dias EC, Javitt DC. Developmental trajectory of mismatch negativity and visual event-related potentials in healthy controls: Implications for neurodevelopmental vs. neurodegenerative models of schizophrenia. Schizophrenia Research. PMID 29033283 DOI: 10.1016/j.schres.2017.09.047  0.96
2017 Lee M, Balla A, Sershen H, Sehatpour P, Lakatos P, Javitt DC. Rodent Mismatch Negativity (MMN)/Theta Neuro-Oscillatory Response as a Translational Neurophysiological Biomarker for N-Methyl-D-Aspartate Receptor-Based New Treatment Development in Schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 28816240 DOI: 10.1038/npp.2017.176  0.96
2017 Lee M, Sehatpour P, Dias EC, Silipo GS, Kantrowitz JT, Martinez AM, Javitt DC. A tale of two sites: Differential impairment of frequency and duration mismatch negativity across a primarily inpatient versus a primarily outpatient site in schizophrenia. Schizophrenia Research. PMID 28779851 DOI: 10.1016/j.schres.2017.07.032  0.96
2017 Avissar M, Xie S, Vail B, Lopez-Calderon J, Wang Y, Javitt DC. Meta-analysis of mismatch negativity to simple versus complex deviants in schizophrenia. Schizophrenia Research. PMID 28709770 DOI: 10.1016/j.schres.2017.07.009  0.4
2017 Javitt DC, Lee M, Kantrowitz JT, Martinez A. Mismatch negativity as a biomarker of theta band oscillatory dysfunction in schizophrenia. Schizophrenia Research. PMID 28666633 DOI: 10.1016/j.schres.2017.06.023  0.92
2017 Kantrowitz JT, Nolan KA, Epstein ML, Lehrfeld N, Shope C, Petkova E, Javitt DC. Neurophysiological Effects of Bitopertin in Schizophrenia. Journal of Clinical Psychopharmacology. PMID 28590364 DOI: 10.1097/JCP.0000000000000722  0.64
2017 Perrin MA, Kantrowitz JT, Silipo G, Dias E, Jabado O, Javitt DC. Mismatch negativity (MMN) to spatial deviants and behavioral spatial discrimination ability in the etiology of auditory verbal hallucinations and thought disorder in schizophrenia. Schizophrenia Research. PMID 28532686 DOI: 10.1016/j.schres.2017.05.012  0.72
2017 Kantrowitz JT, Epstein ML, Lee M, Lehrfeld N, Nolan KA, Shope C, Petkova E, Silipo G, Javitt DC. Improvement in mismatch negativity generation during d-serine treatment in schizophrenia: Correlation with symptoms. Schizophrenia Research. PMID 28318835 DOI: 10.1016/j.schres.2017.02.027  0.72
2016 Kantrowitz JT, Epstein ML, Beggel O, Rohrig S, Lehrfeld JM, Revheim N, Lehrfeld NP, Reep J, Parker E, Silipo G, Ahissar M, Javitt DC. Neurophysiological mechanisms of cortical plasticity impairments in schizophrenia and modulation by the NMDA receptor agonist D-serine. Brain : a Journal of Neurology. 139: 3281-3295. PMID 27913408 DOI: 10.1093/brain/aww262  0.72
2016 Trémeau F, Antonius D, Malaspina D, Goff DC, Javitt DC. Loneliness in schizophrenia and its possible correlates. An exploratory study. Psychiatry Research. 246: 211-217. PMID 27721059 DOI: 10.1016/j.psychres.2016.09.043  0.76
2016 Lakatos P, Barczak A, Neymotin SA, McGinnis T, Ross D, Javitt DC, O'Connell MN. Global dynamics of selective attention and its lapses in primary auditory cortex. Nature Neuroscience. 19: 1707-1717. PMID 27618311 DOI: 10.1038/nn.4386  0.64
2016 Choi J, Corcoran CM, Fiszdon JM, Stevens M, Javitt DC, Deasy M, Haber LC, Dewberry MJ, Pearlson GD. Pupillometer-Based Neurofeedback Cognitive Training to Improve Processing Speed and Social Functioning in Individuals at Clinical High Risk for Psychosis. Psychiatric Rehabilitation Journal. PMID 27560455 DOI: 10.1037/prj0000217  0.4
2016 Zhao G, Denisova K, Sehatpour P, Long J, Gui W, Qiao J, Javitt DC, Wang Z. Fractal Dimension Analysis of Subcortical Gray Matter Structures in Schizophrenia. Plos One. 11: e0155415. PMID 27176232 DOI: 10.1371/journal.pone.0155415  0.76
2016 Tobe RH, Corcoran CM, Breland M, MacKay-Brandt A, Klim C, Colcombe SJ, Leventhal BL, Javitt DC. Differential profiles in auditory social cognition deficits between adults with autism and schizophrenia spectrum disorders: A preliminary analysis. Journal of Psychiatric Research. 79: 21-27. PMID 27131617 DOI: 10.1016/j.jpsychires.2016.04.005  1
2016 Trémeau F, Antonius D, Todorov A, Rebani Y, Ferrari K, Lee SH, Calderone D, Nolan KA, Butler P, Malaspina D, Javitt DC. What can the study of first impressions tell us about attitudinal ambivalence and paranoia in schizophrenia? Psychiatry Research. 238: 86-92. PMID 27086216 DOI: 10.1016/j.psychres.2016.02.014  0.84
2016 Sershen H, Hashim A, Dunlop DS, Suckow RF, Cooper TB, Javitt DC. Modulating NMDA Receptor Function with D-Amino Acid Oxidase Inhibitors: Understanding Functional Activity in PCP-Treated Mouse Model. Neurochemical Research. PMID 26857796 DOI: 10.1007/s11064-016-1838-8  1
2015 Bedi G, Carrillo F, Cecchi GA, Slezak DF, Sigman M, Mota NB, Ribeiro S, Javitt DC, Copelli M, Corcoran CM. Automated analysis of free speech predicts psychosis onset in high-risk youths. Npj Schizophrenia. 1: 15030. PMID 27336038 DOI: 10.1038/npjschz.2015.30  0.4
2015 van Atteveldt N, Musacchia G, Zion-Golumbic E, Sehatpour P, Javitt DC, Schroeder C. Complementary fMRI and EEG evidence for more efficient neural processing of rhythmic vs. unpredictably timed sounds. Frontiers in Psychology. 6: 1663. PMID 26579044 DOI: 10.3389/fpsyg.2015.01663  0.76
2015 Yee CM, Javitt DC, Miller GA. Replacing DSM Categorical Analyses With Dimensional Analyses in Psychiatry Research: The Research Domain Criteria Initiative. Jama Psychiatry. 1159-1160. PMID 26559005 DOI: 10.1001/jamapsychiatry.2015.1900  0.76
2015 Kantrowitz JT, Hoptman MJ, Leitman DI, Moreno-Ortega M, Lehrfeld JM, Dias E, Sehatpour P, Laukka P, Silipo G, Javitt DC. Neural Substrates of Auditory Emotion Recognition Deficits in Schizophrenia. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 35: 14909-21. PMID 26538659 DOI: 10.1523/JNEUROSCI.4603-14.2015  0.76
2015 Trémeau F, Antonius D, Todorov A, Rebani Y, Ferrari K, Lee SH, Calderone D, Nolan KA, Butler P, Malaspina D, Javitt DC. Implicit emotion perception in schizophrenia. Journal of Psychiatric Research. 71: 112-119. PMID 26473695 DOI: 10.1016/j.jpsychires.2015.10.001  0.76
2015 Kantrowitz JT, Woods SW, Petkova E, Cornblatt B, Corcoran CM, Chen H, Silipo G, Javitt DC. D-serine for the treatment of negative symptoms in individuals at clinical high risk of schizophrenia: a pilot, double-blind, placebo-controlled, randomised parallel group mechanistic proof-of-concept trial. The Lancet. Psychiatry. 2: 403-12. PMID 26360284 DOI: 10.1016/S2215-0366(15)00098-X  1
2015 Javitt DC, Sweet RA. Auditory dysfunction in schizophrenia: integrating clinical and basic features. Nature Reviews. Neuroscience. 16: 535-50. PMID 26289573 DOI: 10.1038/nrn4002  0.76
2015 Martínez A, Gaspar PA, Hillyard SA, Bickel S, Lakatos P, Dias EC, Javitt DC. Neural oscillatory deficits in schizophrenia predict behavioral and neurocognitive impairments. Frontiers in Human Neuroscience. 9: 371. PMID 26190988 DOI: 10.3389/fnhum.2015.00371  1
2015 Corcoran CM, Keilp JG, Kayser J, Klim C, Butler PD, Bruder GE, Gur RC, Javitt DC. Emotion recognition deficits as predictors of transition in individuals at clinical high risk for schizophrenia: a neurodevelopmental perspective. Psychological Medicine. 45: 2959-73. PMID 26040537 DOI: 10.1017/S0033291715000902  0.96
2015 Carrión RE, Cornblatt BA, McLaughlin D, Chang J, Auther AM, Olsen RH, Javitt DC. Contributions of early cortical processing and reading ability to functional status in individuals at clinical high risk for psychosis. Schizophrenia Research. 164: 1-7. PMID 25728833 DOI: 10.1016/j.schres.2015.01.030  1
2015 Javitt DC. Neurophysiological models for new treatment development in schizophrenia: early sensory approaches. Annals of the New York Academy of Sciences. 1344: 92-104. PMID 25721890 DOI: 10.1111/nyas.12689  1
2015 Levin R, Dor-Abarbanel AE, Edelman S, Durrant AR, Hashimoto K, Javitt DC, Heresco-Levy U. Behavioral and cognitive effects of the N-methyl-D-aspartate receptor co-agonist D-serine in healthy humans: initial findings. Journal of Psychiatric Research. 61: 188-95. PMID 25554623 DOI: 10.1016/j.jpsychires.2014.12.007  1
2015 Javitt DC, Freedman R. Sensory processing dysfunction in the personal experience and neuronal machinery of schizophrenia. The American Journal of Psychiatry. 172: 17-31. PMID 25553496 DOI: 10.1176/appi.ajp.2014.13121691  1
2015 Heresco-Levy U, Durrant AR, Ermilov M, Javitt DC, Miya K, Mori H. Clinical and electrophysiological effects of D-serine in a schizophrenia patient positive for anti-N-methyl-D-aspartate receptor antibodies. Biological Psychiatry. 77: e27-9. PMID 25442007 DOI: 10.1016/j.biopsych.2014.08.023  1
2015 Corcoran CM, Keilp JG, Kayser J, Klim C, Butler PD, Bruder GE, Gur RC, Javitt DC. Emotion recognition deficits as predictors of transition in individuals at clinical high risk for schizophrenia: a neurodevelopmental perspective Psychological Medicine. DOI: 10.1017/S0033291715000902  1
2015 Javitt DC. Meeting overview: Sensory perception and schizophrenia, Lausanne, Switzerland June 31-July 1, 2014 Schizophrenia Research: Cognition. 2: 42-45. DOI: 10.1016/j.scog.2015.04.003  0.76
2014 Petkova E, Lu F, Kantrowitz J, Sanchez JL, Lehrfeld J, Scaramello N, Silipo G, DiCostanza J, Ross M, Su Z, Javitt DC, Butler PD. Auditory tasks for assessment of sensory function and affective prosody in schizophrenia. Comprehensive Psychiatry. 55: 1862-74. PMID 25214372 DOI: 10.1016/j.comppsych.2014.08.046  1
2014 Revheim N, Corcoran CM, Dias E, Hellmann E, Martinez A, Butler PD, Lehrfeld JM, DiCostanzo J, Albert J, Javitt DC. Reading deficits in schizophrenia and individuals at high clinical risk: relationship to sensory function, course of illness, and psychosocial outcome. The American Journal of Psychiatry. 171: 949-59. PMID 25178752 DOI: 10.1176/appi.ajp.2014.13091196  1
2014 Trémeau F, Antonius D, Nolan K, Butler P, Javitt DC. Immediate affective motivation is not impaired in schizophrenia. Schizophrenia Research. 159: 157-63. PMID 25159096 DOI: 10.1016/j.schres.2014.08.001  1
2014 Hoptman MJ, Antonius D, Mauro CJ, Parker EM, Javitt DC. Cortical thinning, functional connectivity, and mood-related impulsivity in schizophrenia: relationship to aggressive attitudes and behavior. The American Journal of Psychiatry. 171: 939-48. PMID 25073506 DOI: 10.1176/appi.ajp.2014.13111553  1
2014 Kantrowitz JT, Scaramello N, Jakubovitz A, Lehrfeld JM, Laukka P, Elfenbein HA, Silipo G, Javitt DC. Amusia and protolanguage impairments in schizophrenia. Psychological Medicine. 44: 2739-48. PMID 25066878 DOI: 10.1017/S0033291714000373  1
2014 Javitt DC. Distress intolerance, kynurenic acid, and schizophrenia. Jama Psychiatry. 71: 749-50. PMID 24806109 DOI: 10.1001/jamapsychiatry.2014.518  1
2014 Brunoni AR, Shiozawa P, Truong D, Javitt DC, Elkis H, Fregni F, Bikson M. Understanding tDCS effects in schizophrenia: a systematic review of clinical data and an integrated computation modeling analysis. Expert Review of Medical Devices. 11: 383-94. PMID 24754366 DOI: 10.1586/17434440.2014.911082  1
2014 Poels EM, Kegeles LS, Kantrowitz JT, Javitt DC, Lieberman JA, Abi-Dargham A, Girgis RR. Glutamatergic abnormalities in schizophrenia: a review of proton MRS findings. Schizophrenia Research. 152: 325-32. PMID 24418122 DOI: 10.1016/j.schres.2013.12.013  1
2014 Poels EM, Kegeles LS, Kantrowitz JT, Slifstein M, Javitt DC, Lieberman JA, Abi-Dargham A, Girgis RR. Imaging glutamate in schizophrenia: review of findings and implications for drug discovery. Molecular Psychiatry. 19: 20-9. PMID 24166406 DOI: 10.1038/mp.2013.136  1
2014 Kantrowitz JT, Hoptman MJ, Leitman DI, Silipo G, Javitt DC. The 5% difference: early sensory processing predicts sarcasm perception in schizophrenia and schizo-affective disorder. Psychological Medicine. 44: 25-36. PMID 23611263 DOI: 10.1017/S0033291713000834  1
2014 Javitt DC, Liu J, Liu MT, Maroney M, Mathis AS. Participating faculty: Balancing therapeutic safety and efficacy to improve clinical and economic outcomes in schizophrenia [CME/CPE] American Journal of Managed Care. 20.  1
2013 Smiley JF, Hackett TA, Preuss TM, Bleiwas C, Figarsky K, Mann JJ, Rosoklija G, Javitt DC, Dwork AJ. Hemispheric asymmetry of primary auditory cortex and Heschl's gyrus in schizophrenia and nonpsychiatric brains. Psychiatry Research. 214: 435-43. PMID 24148910 DOI: 10.1016/j.pscychresns.2013.08.009  1
2013 Ermilov M, Gelfin E, Levin R, Lichtenberg P, Hashimoto K, Javitt DC, Heresco-Levy U. A pilot double-blind comparison of d-serine and high-dose olanzapine in treatment-resistant patients with schizophrenia. Schizophrenia Research. 150: 604-5. PMID 24094884 DOI: 10.1016/j.schres.2013.09.018  1
2013 Dias EC, Bickel S, Epstein ML, Sehatpour P, Javitt DC. Abnormal task modulation of oscillatory neural activity in schizophrenia. Frontiers in Psychology. 4: 540. PMID 23986729 DOI: 10.3389/fpsyg.2013.00540  1
2013 Spering M, Dias EC, Sanchez JL, Schütz AC, Javitt DC. Efference copy failure during smooth pursuit eye movements in schizophrenia. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 11779-87. PMID 23864667 DOI: 10.1523/JNEUROSCI.0578-13.2013  1
2013 Lakatos P, Schroeder CE, Leitman DI, Javitt DC. Predictive suppression of cortical excitability and its deficit in schizophrenia. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 11692-702. PMID 23843536 DOI: 10.1523/JNEUROSCI.0010-13.2013  1
2013 Javitt DC. Harnessing N-methyl-d-aspartate receptors for new treatment development in psychiatry: positive lessons from negative studies. The American Journal of Psychiatry. 170: 699-702. PMID 23820828 DOI: 10.1176/appi.ajp.2013.13040503  1
2013 Trémeau F, Goldman J, Antonius D, Javitt DC. Inpatients with schizophrenia report impaired situational motivation but intact global and social motivation. Psychiatry Research. 210: 43-9. PMID 23796827 DOI: 10.1016/j.psychres.2013.05.031  1
2013 Lakatos P, Musacchia G, O'Connel MN, Falchier AY, Javitt DC, Schroeder CE. The spectrotemporal filter mechanism of auditory selective attention. Neuron. 77: 750-61. PMID 23439126 DOI: 10.1016/j.neuron.2012.11.034  1
2013 Heresco-Levy U, Shoham S, Javitt DC. Glycine site agonists of the N-methyl-D-aspartate receptor and Parkinson's disease: a hypothesis. Movement Disorders : Official Journal of the Movement Disorder Society. 28: 419-24. PMID 23427107 DOI: 10.1002/mds.25306  1
2013 Guilfoyle DN, Gerum SV, Sanchez JL, Balla A, Sershen H, Javitt DC, Hoptman MJ. Functional connectivity fMRI in mouse brain at 7T using isoflurane. Journal of Neuroscience Methods. 214: 144-8. PMID 23376497 DOI: 10.1016/j.jneumeth.2013.01.019  1
2013 Jarskog LF, Dong Z, Kangarlu A, Colibazzi T, Girgis RR, Kegeles LS, Barch DM, Buchanan RW, Csernansky JG, Goff DC, Harms MP, Javitt DC, Keefe RS, McEvoy JP, McMahon RP, et al. Effects of davunetide on N-acetylaspartate and choline in dorsolateral prefrontal cortex in patients with schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 38: 1245-52. PMID 23325325 DOI: 10.1038/npp.2013.23  1
2013 Freedman R, Lewis DA, Michels R, Pine DS, Schultz SK, Tamminga CA, Gabbard GO, Gau SS, Javitt DC, Oquendo MA, Shrout PE, Vieta E, Yager J. The initial field trials of DSM-5: new blooms and old thorns. The American Journal of Psychiatry. 170: 1-5. PMID 23288382 DOI: 10.1176/appi.ajp.2012.12091189  1
2013 Calderone DJ, Martinez A, Zemon V, Hoptman MJ, Hu G, Watkins JE, Javitt DC, Butler PD. Comparison of psychophysical, electrophysiological, and fMRI assessment of visual contrast responses in patients with schizophrenia. Neuroimage. 67: 153-62. PMID 23194815 DOI: 10.1016/j.neuroimage.2012.11.019  1
2013 Heresco-Levy U, Gelfin G, Bloch B, Levin R, Edelman S, Javitt DC, Kremer I. A randomized add-on trial of high-dose D-cycloserine for treatment-resistant depression. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 16: 501-6. PMID 23174090 DOI: 10.1017/S1461145712000910  1
2013 Woods SW, Walsh BC, Hawkins KA, Miller TJ, Saksa JR, D'Souza DC, Pearlson GD, Javitt DC, McGlashan TH, Krystal JH. Glycine treatment of the risk syndrome for psychosis: report of two pilot studies. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 23: 931-40. PMID 23089076 DOI: 10.1016/j.euroneuro.2012.09.008  1
2013 Calderone DJ, Hoptman MJ, Martínez A, Nair-Collins S, Mauro CJ, Bar M, Javitt DC, Butler PD. Contributions of low and high spatial frequency processing to impaired object recognition circuitry in schizophrenia. Cerebral Cortex (New York, N.Y. : 1991). 23: 1849-58. PMID 22735157 DOI: 10.1093/cercor/bhs169  1
2013 Kantrowitz JT, Leitman DI, Lehrfeld JM, Laukka P, Juslin PN, Butler PD, Silipo G, Javitt DC. Reduction in tonal discriminations predicts receptive emotion processing deficits in schizophrenia and schizoaffective disorder. Schizophrenia Bulletin. 39: 86-93. PMID 21725063 DOI: 10.1093/schbul/sbr060  1
2013 Calderone DJ, Martinez A, Zemon V, Hoptman MJ, Hu G, Watkins JE, Javitt DC, Butler PD. Corrigendum to "Comparison of psychophysical, electrophysiological, and fMRI assessment of visual contrast responses in patients with schizophrenia" [Neuroimage 67C (2013) 153-162] Neuroimage. 83: 1110. DOI: 10.1016/j.neuroimage.2013.07.059  1
2012 Martínez A, Revheim N, Butler PD, Guilfoyle DN, Dias EC, Javitt DC. Impaired magnocellular/dorsal stream activation predicts impaired reading ability in schizophrenia. Neuroimage. Clinical. 2: 8-16. PMID 24179753 DOI: 10.1016/j.nicl.2012.09.006  1
2012 Nooner KB, Colcombe SJ, Tobe RH, Mennes M, Benedict MM, Moreno AL, Panek LJ, Brown S, Zavitz ST, Li Q, Sikka S, Gutman D, Bangaru S, Schlachter RT, Kamiel SM, ... ... Javitt DC, et al. The NKI-Rockland Sample: A Model for Accelerating the Pace of Discovery Science in Psychiatry. Frontiers in Neuroscience. 6: 152. PMID 23087608 DOI: 10.3389/fnins.2012.00152  1
2012 Javitt DC. Glycine transport inhibitors in the treatment of schizophrenia. Handbook of Experimental Pharmacology. 367-99. PMID 23027421 DOI: 10.1007/978-3-642-25758-2_12  1
2012 Javitt DC, Zukin SR, Heresco-Levy U, Umbricht D. Has an angel shown the way? Etiological and therapeutic implications of the PCP/NMDA model of schizophrenia. Schizophrenia Bulletin. 38: 958-66. PMID 22987851 DOI: 10.1093/schbul/sbs069  1
2012 Javitt DC. Twenty-five years of glutamate in schizophrenia: are we there yet? Schizophrenia Bulletin. 38: 911-3. PMID 22987849 DOI: 10.1093/schbul/sbs100  1
2012 Hoptman MJ, Zuo XN, D'Angelo D, Mauro CJ, Butler PD, Milham MP, Javitt DC. Decreased interhemispheric coordination in schizophrenia: a resting state fMRI study. Schizophrenia Research. 141: 1-7. PMID 22910401 DOI: 10.1016/j.schres.2012.07.027  1
2012 Weiser M, Heresco-Levy U, Davidson M, Javitt DC, Werbeloff N, Gershon AA, Abramovich Y, Amital D, Doron A, Konas S, Levkovitz Y, Liba D, Teitelbaum A, Mashiach M, Zimmerman Y. A multicenter, add-on randomized controlled trial of low-dose d-serine for negative and cognitive symptoms of schizophrenia. The Journal of Clinical Psychiatry. 73: e728-34. PMID 22795211 DOI: 10.4088/JCP.11m07031  1
2012 Bickel S, Dias EC, Epstein ML, Javitt DC. Expectancy-related modulations of neural oscillations in continuous performance tasks. Neuroimage. 62: 1867-76. PMID 22691613 DOI: 10.1016/j.neuroimage.2012.06.009  1
2012 Balla A, Schneider S, Sershen H, Javitt DC. Effects of novel, high affinity glycine transport inhibitors on frontostriatal dopamine release in a rodent model of schizophrenia. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 22: 902-10. PMID 22561005 DOI: 10.1016/j.euroneuro.2012.03.006  1
2012 Trémeau F, Nolan KA, Malaspina D, Javitt DC. Behavioral validation of avolition in schizophrenia. Schizophrenia Research. 138: 255-61. PMID 22398126 DOI: 10.1016/j.schres.2012.02.018  1
2012 Chouake T, Levy T, Javitt DC, Lavidor M. Magnocellular training improves visual word recognition. Frontiers in Human Neuroscience. 6: 14. PMID 22363277 DOI: 10.3389/fnhum.2012.00014  1
2012 Gold R, Butler P, Revheim N, Leitman DI, Hansen JA, Gur RC, Kantrowitz JT, Laukka P, Juslin PN, Silipo GS, Javitt DC. Auditory emotion recognition impairments in schizophrenia: relationship to acoustic features and cognition. The American Journal of Psychiatry. 169: 424-32. PMID 22362394 DOI: 10.1176/appi.ajp.2011.11081230  1
2012 Kantrowitz J, Javitt DC. Glutamatergic transmission in schizophrenia: from basic research to clinical practice. Current Opinion in Psychiatry. 25: 96-102. PMID 22297716 DOI: 10.1097/YCO.0b013e32835035b2  1
2012 Friedman T, Sehatpour P, Dias E, Perrin M, Javitt DC. Differential relationships of mismatch negativity and visual p1 deficits to premorbid characteristics and functional outcome in schizophrenia. Biological Psychiatry. 71: 521-9. PMID 22192361 DOI: 10.1016/j.biopsych.2011.10.037  1
2012 Javitt DC, Buchanan RW, Keefe RS, Kern R, McMahon RP, Green MF, Lieberman J, Goff DC, Csernansky JG, McEvoy JP, Jarskog F, Seidman LJ, Gold JM, Kimhy D, Nolan KS, et al. Effect of the neuroprotective peptide davunetide (AL-108) on cognition and functional capacity in schizophrenia. Schizophrenia Research. 136: 25-31. PMID 22169248 DOI: 10.1016/j.schres.2011.11.001  1
2012 Yang L, Chen S, Chen CM, Khan F, Forchelli G, Javitt DC. Schizophrenia, culture and neuropsychology: sensory deficits, language impairments and social functioning in Chinese-speaking schizophrenia patients. Psychological Medicine. 42: 1485-94. PMID 22099474 DOI: 10.1017/S0033291711002224  1
2012 Moghaddam B, Javitt D. From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 37: 4-15. PMID 21956446 DOI: 10.1038/npp.2011.181  1
2012 Martínez A, Hillyard SA, Bickel S, Dias EC, Butler PD, Javitt DC. Consequences of magnocellular dysfunction on processing attended information in schizophrenia. Cerebral Cortex (New York, N.Y. : 1991). 22: 1282-93. PMID 21840846 DOI: 10.1093/cercor/bhr195  1
2012 Gelfin E, Kaufman Y, Korn-Lubetzki I, Bloch B, Kremer I, Javitt DC, Heresco-Levy U. D-serine adjuvant treatment alleviates behavioural and motor symptoms in Parkinson's disease. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 15: 543-9. PMID 21733283 DOI: 10.1017/S1461145711001015  1
2011 Leitman DI, Sehatpour P, Garidis C, Gomez-Ramirez M, Javitt DC. Preliminary Evidence of Pre-Attentive Distinctions of Frequency-Modulated Tones that Convey Affect. Frontiers in Human Neuroscience. 5: 96. PMID 22053152 DOI: 10.3389/fnhum.2011.00096  0.96
2011 Javitt DC, Schoepp D, Kalivas PW, Volkow ND, Zarate C, Merchant K, Bear MF, Umbricht D, Hajos M, Potter WZ, Lee CM. Translating glutamate: from pathophysiology to treatment. Science Translational Medicine. 3: 102mr2. PMID 21957170 DOI: 10.1126/scitranslmed.3002804  1
2011 Knebel JF, Javitt DC, Murray MM. Impaired early visual response modulations to spatial information in chronic schizophrenia. Psychiatry Research. 193: 168-76. PMID 21764264 DOI: 10.1016/j.pscychresns.2011.02.006  1
2011 Jacobson L, Javitt DC, Lavidor M. Activation of inhibition: diminishing impulsive behavior by direct current stimulation over the inferior frontal gyrus. Journal of Cognitive Neuroscience. 23: 3380-7. PMID 21452949 DOI: 10.1162/jocn_a_00020  1
2011 Dias EC, Butler PD, Hoptman MJ, Javitt DC. Early sensory contributions to contextual encoding deficits in schizophrenia. Archives of General Psychiatry. 68: 654-64. PMID 21383251 DOI: 10.1001/archgenpsychiatry.2011.17  1
2011 Smiley JF, Rosoklija G, Mancevski B, Pergolizzi D, Figarsky K, Bleiwas C, Duma A, Mann JJ, Javitt DC, Dwork AJ. Hemispheric comparisons of neuron density in the planum temporale of schizophrenia and nonpsychiatric brains. Psychiatry Research. 192: 1-11. PMID 21377842 DOI: 10.1016/j.pscychresns.2010.11.007  1
2011 Buchanan RW, Keefe RS, Lieberman JA, Barch DM, Csernansky JG, Goff DC, Gold JM, Green MF, Jarskog LF, Javitt DC, Kimhy D, Kraus MS, McEvoy JP, Mesholam-Gately RI, Seidman LJ, et al. A randomized clinical trial of MK-0777 for the treatment of cognitive impairments in people with schizophrenia. Biological Psychiatry. 69: 442-9. PMID 21145041 DOI: 10.1016/j.biopsych.2010.09.052  1
2011 Luck SJ, Mathalon DH, O'Donnell BF, Hämäläinen MS, Spencer KM, Javitt DC, Uhlhaas PJ. A roadmap for the development and validation of event-related potential biomarkers in schizophrenia research. Biological Psychiatry. 70: 28-34. PMID 21111401 DOI: 10.1016/j.biopsych.2010.09.021  1
2011 Nemrodov D, Harpaz Y, Javitt DC, Lavidor M. ERP evidence of hemispheric independence in visual word recognition. Brain and Language. 118: 72-80. PMID 20542549 DOI: 10.1016/j.bandl.2010.04.004  1
2011 Kantrowitz JT, Javitt DC. The authors respond Current Psychiatry. 10: 4.  1
2011 Kantrowitz JT, Javitt DC. Glutamate: New hope for Schizophrenia treatment Current Psychiatry. 10: 69-74.  1
2010 Kantrowitz JT, Javitt DC. Thinking glutamatergically: changing concepts of schizophrenia based upon changing neurochemical models. Clinical Schizophrenia & Related Psychoses. 4: 189-200. PMID 20880830 DOI: 10.3371/CSRP.4.3.6  1
2010 Javitt DC. Glutamatergic theories of schizophrenia. The Israel Journal of Psychiatry and Related Sciences. 47: 4-16. PMID 20686195  1
2010 Sehatpour P, Dias EC, Butler PD, Revheim N, Guilfoyle DN, Foxe JJ, Javitt DC. Impaired visual object processing across an occipital-frontal-hippocampal brain network in schizophrenia: an integrated neuroimaging study. Archives of General Psychiatry. 67: 772-82. PMID 20679585 DOI: 10.1001/archgenpsychiatry.2010.85  1
2010 Perrin MA, Butler PD, DiCostanzo J, Forchelli G, Silipo G, Javitt DC. Spatial localization deficits and auditory cortical dysfunction in schizophrenia. Schizophrenia Research. 124: 161-8. PMID 20619608 DOI: 10.1016/j.schres.2010.06.004  1
2010 Kantrowitz JT, Malhotra AK, Cornblatt B, Silipo G, Balla A, Suckow RF, D'Souza C, Saksa J, Woods SW, Javitt DC. High dose D-serine in the treatment of schizophrenia. Schizophrenia Research. 121: 125-30. PMID 20541910 DOI: 10.1016/j.schres.2010.05.012  1
2010 Leitman DI, Sehatpour P, Higgins BA, Foxe JJ, Silipo G, Javitt DC. Sensory deficits and distributed hierarchical dysfunction in schizophrenia. The American Journal of Psychiatry. 167: 818-27. PMID 20478875 DOI: 10.1176/appi.ajp.2010.09030338  1
2010 Kantrowitz JT, Oakman E, Bickel S, Citrome L, Spielman A, Silipo G, Battaglia J, Javitt DC. The importance of a good night's sleep: an open-label trial of the sodium salt of gamma-hydroxybutyric acid in insomnia associated with schizophrenia. Schizophrenia Research. 120: 225-6. PMID 20435443 DOI: 10.1016/j.schres.2010.03.035  1
2010 Kantrowitz JT, Javitt DC. N-methyl-d-aspartate (NMDA) receptor dysfunction or dysregulation: the final common pathway on the road to schizophrenia? Brain Research Bulletin. 83: 108-21. PMID 20417696 DOI: 10.1016/j.brainresbull.2010.04.006  1
2010 Leitman DI, Wolf DH, Ragland JD, Laukka P, Loughead J, Valdez JN, Javitt DC, Turetsky BI, Gur RC. "It's Not What You Say, But How You Say it": A Reciprocal Temporo-frontal Network for Affective Prosody. Frontiers in Human Neuroscience. 4: 19. PMID 20204074 DOI: 10.3389/fnhum.2010.00019  1
2010 Butler PD, Schechter I, Revheim N, Silipo G, Javitt DC. Has an important test been overlooked? Closure flexibility in schizophrenia. Schizophrenia Research. 118: 20-5. PMID 20110157 DOI: 10.1016/j.schres.2010.01.005  1
2010 Trémeau F, Antonius D, Cacioppo JT, Ziwich R, Butler P, Malaspina D, Javitt DC. Anticipated, on-line and remembered positive experience in schizophrenia. Schizophrenia Research. 122: 199-205. PMID 19906511 DOI: 10.1016/j.schres.2009.10.019  1
2010 Hoptman MJ, Zuo XN, Butler PD, Javitt DC, D'Angelo D, Mauro CJ, Milham MP. Amplitude of low-frequency oscillations in schizophrenia: a resting state fMRI study. Schizophrenia Research. 117: 13-20. PMID 19854028 DOI: 10.1016/j.schres.2009.09.030  1
2010 Hoptman MJ, D'Angelo D, Catalano D, Mauro CJ, Shehzad ZE, Kelly AM, Castellanos FX, Javitt DC, Milham MP. Amygdalofrontal functional disconnectivity and aggression in schizophrenia. Schizophrenia Bulletin. 36: 1020-8. PMID 19336392 DOI: 10.1093/schbul/sbp012  1
2010 Wylie GR, Clark EA, Butler PD, Javitt DC. Schizophrenia patients show task switching deficits consistent with N-methyl-d-aspartate system dysfunction but not global executive deficits: implications for pathophysiology of executive dysfunction in schizophrenia. Schizophrenia Bulletin. 36: 585-94. PMID 18835838 DOI: 10.1093/schbul/sbn119  1
2010 Leitman DI, Laukka P, Juslin PN, Saccente E, Butler P, Javitt DC. Getting the cue: sensory contributions to auditory emotion recognition impairments in schizophrenia. Schizophrenia Bulletin. 36: 545-56. PMID 18791077 DOI: 10.1093/schbul/sbn115  1
2009 Leitman DI, Sehatpour P, Shpaner M, Foxe JJ, Javitt DC. Mismatch negativity to tonal contours suggests preattentive perception of prosodic content. Brain Imaging and Behavior. 3: 284-91. PMID 22005991 DOI: 10.1007/s11682-009-9070-7  1
2009 Lakatos P, O'Connell MN, Barczak A, Mills A, Javitt DC, Schroeder CE. The leading sense: supramodal control of neurophysiological context by attention. Neuron. 64: 419-30. PMID 19914189 DOI: 10.1016/j.neuron.2009.10.014  1
2009 Javitt DC. Sensory processing in schizophrenia: neither simple nor intact. Schizophrenia Bulletin. 35: 1059-64. PMID 19833806 DOI: 10.1093/schbul/sbp110  1
2009 Butler PD, Abeles IY, Weiskopf NG, Tambini A, Jalbrzikowski M, Legatt ME, Zemon V, Loughead J, Gur RC, Javitt DC. Sensory contributions to impaired emotion processing in schizophrenia. Schizophrenia Bulletin. 35: 1095-107. PMID 19793797 DOI: 10.1093/schbul/sbp109  1
2009 Kantrowitz JT, Butler PD, Schecter I, Silipo G, Javitt DC. Seeing the world dimly: the impact of early visual deficits on visual experience in schizophrenia. Schizophrenia Bulletin. 35: 1085-94. PMID 19793795 DOI: 10.1093/schbul/sbp100  1
2009 Kantrowitz JT, Citrome L, Javitt DC. A review of tolerability and abuse liability of gamma-hydroxybutyric acid for insomnia in patients with schizophrenia. Clinical Therapeutics. 31: 1360-73. PMID 19698899 DOI: 10.1016/j.clinthera.2009.07.005  1
2009 Smiley JF, Rosoklija G, Mancevski B, Mann JJ, Dwork AJ, Javitt DC. Altered volume and hemispheric asymmetry of the superficial cortical layers in the schizophrenia planum temporale. The European Journal of Neuroscience. 30: 449-63. PMID 19656176 DOI: 10.1111/j.1460-9568.2009.06838.x  1
2009 Kantrowitz J, Citrome L, Javitt D. GABAB receptors, schizophrenia and sleep dysfunction: A review of the relationship and its potential clinical and therapeutic implications Cns Drugs. 23: 681-691. PMID 19594197 DOI: 10.2165/00023210-200923080-00005  1
2009 Kantrowitz JT, Revheim N, Pasternak R, Silipo G, Javitt DC. It's all in the cards: effect of stimulus manipulation on Wisconsin Card Sorting Test performance in schizophrenia. Psychiatry Research. 168: 198-204. PMID 19573928 DOI: 10.1016/j.psychres.2008.05.013  1
2009 Javitt DC. Glycine transport inhibitors for the treatment of schizophrenia: symptom and disease modification. Current Opinion in Drug Discovery & Development. 12: 468-78. PMID 19562643  1
2009 Bickel S, Javitt DC. Neurophysiological and neurochemical animal models of schizophrenia: focus on glutamate. Behavioural Brain Research. 204: 352-62. PMID 19433116 DOI: 10.1016/j.bbr.2009.05.005  1
2009 Balla A, Nattini ME, Sershen H, Lajtha A, Dunlop DS, Javitt DC. GABAB/NMDA receptor interaction in the regulation of extracellular dopamine levels in rodent prefrontal cortex and striatum. Neuropharmacology. 56: 915-21. PMID 19371582 DOI: 10.1016/j.neuropharm.2009.01.021  1
2009 Javitt DC. When doors of perception close: bottom-up models of disrupted cognition in schizophrenia. Annual Review of Clinical Psychology. 5: 249-75. PMID 19327031 DOI: 10.1146/annurev.clinpsy.032408.153502  1
2009 Freedman R, Lewis DA, Michels R, Pine DS, Schultz SK, Tamminga CA, Andreasen NC, Brady KT, Brent DA, Brzustowicz L, Carter CS, Eisenberg L, Goldman H, Javitt DC, Leibenluft E, et al. Conflict of interest-- an issue for every psychiatrist. The American Journal of Psychiatry. 166: 274. PMID 19255048 DOI: 10.1176/appi.ajp.2009.09010093  1
2009 Greenberg WM, Benedict MM, Doerfer J, Perrin M, Panek L, Cleveland WL, Javitt DC. Adjunctive glycine in the treatment of obsessive-compulsive disorder in adults. Journal of Psychiatric Research. 43: 664-70. PMID 19046587 DOI: 10.1016/j.jpsychires.2008.10.007  1
2009 Trémeau F, Antonius D, Cacioppo JT, Ziwich R, Jalbrzikowski M, Saccente E, Silipo G, Butler P, Javitt D. In support of Bleuler: objective evidence for increased affective ambivalence in schizophrenia based upon evocative testing. Schizophrenia Research. 107: 223-31. PMID 18947981 DOI: 10.1016/j.schres.2008.09.020  1
2009 Wylie GR, Murray MM, Javitt DC, Foxe JJ. Distinct neurophysiological mechanisms mediate mixing costs and switch costs. Journal of Cognitive Neuroscience. 21: 105-18. PMID 18476759 DOI: 10.1162/jocn.2009.21009  1
2008 Martínez A, Hillyard SA, Dias EC, Hagler DJ, Butler PD, Guilfoyle DN, Jalbrzikowski M, Silipo G, Javitt DC. Magnocellular pathway impairment in schizophrenia: evidence from functional magnetic resonance imaging. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 7492-500. PMID 18650327 DOI: 10.1523/JNEUROSCI.1852-08.2008  1
2008 Javitt DC. Phenomenology, aetiology and treatment of schizophrenia. Novartis Foundation Symposium. 289: 4-16; discussion 17-. PMID 18497092  1
2008 McCourt ME, Shpaner M, Javitt DC, Foxe JJ. Hemispheric asymmetry and callosal integration of visuospatial attention in schizophrenia: a tachistoscopic line bisection study. Schizophrenia Research. 102: 189-96. PMID 18485672 DOI: 10.1016/j.schres.2008.03.021  1
2008 Butler PD, Tambini A, Yovel G, Jalbrzikowski M, Ziwich R, Silipo G, Kanwisher N, Javitt DC. What's in a face? Effects of stimulus duration and inversion on face processing in schizophrenia. Schizophrenia Research. 103: 283-92. PMID 18450426 DOI: 10.1016/j.schres.2008.03.007  1
2008 Lisman JE, Coyle JT, Green RW, Javitt DC, Benes FM, Heckers S, Grace AA. Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia. Trends in Neurosciences. 31: 234-42. PMID 18395805 DOI: 10.1016/j.tins.2008.02.005  1
2008 Sehatpour P, Molholm S, Schwartz TH, Mahoney JR, Mehta AD, Javitt DC, Stanton PK, Foxe JJ. A human intracranial study of long-range oscillatory coherence across a frontal-occipital-hippocampal brain network during visual object processing. Proceedings of the National Academy of Sciences of the United States of America. 105: 4399-404. PMID 18334648 DOI: 10.1073/pnas.0708418105  1
2008 Javitt DC. Glycine transport inhibitors and the treatment of schizophrenia. Biological Psychiatry. 63: 6-8. PMID 18082555 DOI: 10.1016/j.biopsych.2007.09.017  1
2008 Javitt DC, Spencer KM, Thaker GK, Winterer G, Hajós M. Neurophysiological biomarkers for drug development in schizophrenia. Nature Reviews. Drug Discovery. 7: 68-83. PMID 18064038 DOI: 10.1038/nrd2463  1
2008 Donohoe G, Morris DW, De Sanctis P, Magno E, Montesi JL, Garavan HP, Robertson IH, Javitt DC, Gill M, Corvin AP, Foxe JJ. Early visual processing deficits in dysbindin-associated schizophrenia. Biological Psychiatry. 63: 484-9. PMID 17945199 DOI: 10.1016/j.biopsych.2007.07.022  1
2008 Sershen H, Balla A, Aspromonte JM, Xie S, Cooper TB, Javitt DC. Characterization of interactions between phencyclidine and amphetamine in rodent prefrontal cortex and striatum: implications in NMDA/glycine-site-mediated dopaminergic dysregulation and dopamine transporter function. Neurochemistry International. 52: 119-29. PMID 17716783 DOI: 10.1016/j.neuint.2007.07.011  1
2008 Javitt DC, First MB. Substance Abuse: Phencyclidine Use Disorders Psychiatry: Third Edition. 1: 1090-1099. DOI: 10.1002/9780470515167.ch59  1
2008 Chao M, Flint J, Talmage DA, Bothwell M, Buonanno A, Lu B, Akil H, Malaspina D, Raff MC, Castrén E, Javitt DC, Owen MJ, Giedd JN, Sklar P. General discussion I Novartis Foundation Symposium. 289: 87-93.  1
2008 Chao M, Javitt DC, Raff MC, Lu B, Barde YA, Flint J, Owen MJ, Malaspina D, Tongiorgi E, Buonanno A. Discussion Novartis Foundation Symposium. 289: 17-22.  1
2008 Martínez A, Hillyard SA, Dias EC, Hagler DJ, Butler PD, Guilfoyle DN, Jalbrzikowski M, Silipo G, Javitt DC. Magnocellular pathway impairment in schizophrenia: Evidence from functional magnetic resonance imaging (Journal of Neuroscience (July 23, 2008) (7492-7500)) Journal of Neuroscience. 28: 9319.  1
2007 Ross LA, Saint-Amour D, Leavitt VM, Molholm S, Javitt DC, Foxe JJ. Impaired multisensory processing in schizophrenia: deficits in the visual enhancement of speech comprehension under noisy environmental conditions. Schizophrenia Research. 97: 173-83. PMID 17928202 DOI: 10.1016/j.schres.2007.08.008  1
2007 Buchanan RW, Javitt DC, Marder SR, Schooler NR, Gold JM, McMahon RP, Heresco-Levy U, Carpenter WT. The Cognitive and Negative Symptoms in Schizophrenia Trial (CONSIST): the efficacy of glutamatergic agents for negative symptoms and cognitive impairments. The American Journal of Psychiatry. 164: 1593-602. PMID 17898352 DOI: 10.1176/appi.ajp.2007.06081358  1
2007 Kimhy D, Corcoran C, Harkavy-Friedman JM, Ritzler B, Javitt DC, Malaspina D. Visual form perception: a comparison of individuals at high risk for psychosis, recent onset schizophrenia and chronic schizophrenia. Schizophrenia Research. 97: 25-34. PMID 17884347 DOI: 10.1016/j.schres.2007.08.022  1
2007 Kurylo DD, Pasternak R, Silipo G, Javitt DC, Butler PD. Perceptual organization by proximity and similarity in schizophrenia. Schizophrenia Research. 95: 205-14. PMID 17681736 DOI: 10.1016/j.schres.2007.07.001  1
2007 Martinez A, Ramanathan DS, Foxe JJ, Javitt DC, Hillyard SA. The role of spatial attention in the selection of real and illusory objects. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 7963-73. PMID 17652587 DOI: 10.1523/JNEUROSCI.0031-07.2007  1
2007 Buchanan RW, Freedman R, Javitt DC, Abi-Dargham A, Lieberman JA. Recent advances in the development of novel pharmacological agents for the treatment of cognitive impairments in schizophrenia. Schizophrenia Bulletin. 33: 1120-30. PMID 17641146 DOI: 10.1093/schbul/sbm083  1
2007 Smiley JF, Hackett TA, Ulbert I, Karmas G, Lakatos P, Javitt DC, Schroeder CE. Multisensory convergence in auditory cortex, I. Cortical connections of the caudal superior temporal plane in macaque monkeys. The Journal of Comparative Neurology. 502: 894-923. PMID 17447261 DOI: 10.1002/cne.21325  1
2007 Revheim N, Javitt DC. Reading disability goes beyond consent forms. Psychiatric Services (Washington, D.C.). 58: 566. PMID 17412864 DOI: 10.1176/appi.ps.58.4.566  1
2007 Linn GS, O'Keeffe RT, Lifshitz K, Schroeder C, Javitt DC. Behavioral effects of orally administered glycine in socially housed monkeys chronically treated with phencyclidine. Psychopharmacology. 192: 27-38. PMID 17393142 DOI: 10.1007/s00213-007-0771-6  1
2007 Javitt DC. Glutamate and schizophrenia: phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactions. International Review of Neurobiology. 78: 69-108. PMID 17349858 DOI: 10.1016/S0074-7742(06)78003-5  1
2007 Leitman DI, Hoptman MJ, Foxe JJ, Saccente E, Wylie GR, Nierenberg J, Jalbrzikowski M, Lim KO, Javitt DC. The neural substrates of impaired prosodic detection in schizophrenia and its sensorial antecedents. The American Journal of Psychiatry. 164: 474-82. PMID 17329473 DOI: 10.1176/appi.ajp.164.3.474  1
2007 Javitt DC, Rabinowicz E, Silipo G, Dias EC. Encoding vs. retention: differential effects of cue manipulation on working memory performance in schizophrenia. Schizophrenia Research. 91: 159-68. PMID 17291722 DOI: 10.1016/j.schres.2006.11.024  1
2007 Heresco-Levy U, Bar G, Levin R, Ermilov M, Ebstein RP, Javitt DC. High glycine levels are associated with prepulse inhibition deficits in chronic schizophrenia patients. Schizophrenia Research. 91: 14-21. PMID 17276036 DOI: 10.1016/j.schres.2006.12.003  1
2007 Butler PD, Martinez A, Foxe JJ, Kim D, Zemon V, Silipo G, Mahoney J, Shpaner M, Jalbrzikowski M, Javitt DC. Subcortical visual dysfunction in schizophrenia drives secondary cortical impairments. Brain : a Journal of Neurology. 130: 417-30. PMID 16984902 DOI: 10.1093/brain/awl233  1
2007 Chen CM, Lakatos P, Shah AS, Mehta AD, Givre SJ, Javitt DC, Schroeder CE. Functional anatomy and interaction of fast and slow visual pathways in macaque monkeys. Cerebral Cortex (New York, N.Y. : 1991). 17: 1561-9. PMID 16950866 DOI: 10.1093/cercor/bhl067  1
2007 Ross LA, Saint-Amour D, Leavitt VM, Javitt DC, Foxe JJ. Do you see what I am saying? Exploring visual enhancement of speech comprehension in noisy environments. Cerebral Cortex (New York, N.Y. : 1991). 17: 1147-53. PMID 16785256 DOI: 10.1093/cercor/bhl024  1
2007 Butler PD, Martinez A, Foxe JJ, Kim D, Zemon V, Silipo G, Mahoney J, Shpaner M, Jalbrzikowskil M, Javitt DC. Reply: A few remarks on assessing magnocellular sensitivity in patients with schizophrenia [2] Brain. 130: e84. DOI: 10.1093/brain/awm154  1
2006 Murray MM, Imber ML, Javitt DC, Foxe JJ. Boundary completion is automatic and dissociable from shape discrimination. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 26: 12043-54. PMID 17108178 DOI: 10.1523/JNEUROSCI.3225-06.2006  1
2006 Yeap S, Kelly SP, Sehatpour P, Magno E, Javitt DC, Garavan H, Thakore JH, Foxe JJ. Early visual sensory deficits as endophenotypes for schizophrenia: high-density electrical mapping in clinically unaffected first-degree relatives. Archives of General Psychiatry. 63: 1180-8. PMID 17088498 DOI: 10.1001/archpsyc.63.11.1180  1
2006 Butler PD, Hoptman MJ, Nierenberg J, Foxe JJ, Javitt DC, Lim KO. Visual white matter integrity in schizophrenia. The American Journal of Psychiatry. 163: 2011-3. PMID 17074957 DOI: 10.1176/appi.ajp.163.11.2011  1
2006 Lim KO, Ardekani BA, Nierenberg J, Butler PD, Javitt DC, Hoptman MJ. Voxelwise correlational analyses of white matter integrity in multiple cognitive domains in schizophrenia. The American Journal of Psychiatry. 163: 2008-10. PMID 17074956 DOI: 10.1176/appi.ajp.163.11.2008  1
2006 Ritter W, De Sanctis P, Molholm S, Javitt DC, Foxe JJ. Preattentively grouped tones do not elicit MMN with respect to each other. Psychophysiology. 43: 423-30. PMID 16965603 DOI: 10.1111/j.1469-8986.2006.00423.x  1
2006 Schechter I, Butler PD, Jalbrzikowski M, Pasternak R, Saperstein AM, Javitt DC. A new dimension of sensory dysfunction: stereopsis deficits in schizophrenia. Biological Psychiatry. 60: 1282-4. PMID 16945346 DOI: 10.1016/j.biopsych.2006.03.064  1
2006 Revheim N, Butler PD, Schechter I, Jalbrzikowski M, Silipo G, Javitt DC. Reading impairment and visual processing deficits in schizophrenia. Schizophrenia Research. 87: 238-45. PMID 16890409 DOI: 10.1016/j.schres.2006.06.022  1
2006 Leitman DI, Ziwich R, Pasternak R, Javitt DC. Theory of Mind (ToM) and counterfactuality deficits in schizophrenia: misperception or misinterpretation? Psychological Medicine. 36: 1075-83. PMID 16700967 DOI: 10.1017/S0033291706007653  1
2006 Heresco-Levy U, Javitt DC, Gelfin Y, Gorelik E, Bar M, Blanaru M, Kremer I. Controlled trial of D-cycloserine adjuvant therapy for treatment-resistant major depressive disorder. Journal of Affective Disorders. 93: 239-43. PMID 16677714 DOI: 10.1016/j.jad.2006.03.004  1
2006 Dias EC, McGinnis T, Smiley JF, Foxe JJ, Schroeder CE, Javitt DC. Changing plans: neural correlates of executive control in monkey and human frontal cortex. Experimental Brain Research. 174: 279-91. PMID 16636795 DOI: 10.1007/s00221-006-0444-4  1
2006 Javitt DC. Is the glycine site half saturated or half unsaturated? Effects of glutamatergic drugs in schizophrenia patients. Current Opinion in Psychiatry. 19: 151-7. PMID 16612195 DOI: 10.1097/01.yco.0000214340.14131.bd  1
2006 Umbricht DS, Bates JA, Lieberman JA, Kane JM, Javitt DC. Electrophysiological indices of automatic and controlled auditory information processing in first-episode, recent-onset and chronic schizophrenia. Biological Psychiatry. 59: 762-72. PMID 16497277 DOI: 10.1016/j.biopsych.2005.08.030  1
2006 Martínez A, Teder-Sälejärvi W, Vazquez M, Molholm S, Foxe JJ, Javitt DC, Di Russo F, Worden MS, Hillyard SA. Objects are highlighted by spatial attention. Journal of Cognitive Neuroscience. 18: 298-310. PMID 16494688 DOI: 10.1162/089892906775783642  1
2006 Revheim N, Schechter I, Kim D, Silipo G, Allingham B, Butler P, Javitt DC. Neurocognitive and symptom correlates of daily problem-solving skills in schizophrenia. Schizophrenia Research. 83: 237-45. PMID 16443347 DOI: 10.1016/j.schres.2005.12.849  1
2006 Kim D, Wylie G, Pasternak R, Butler PD, Javitt DC. Magnocellular contributions to impaired motion processing in schizophrenia. Schizophrenia Research. 82: 1-8. PMID 16325377 DOI: 10.1016/j.schres.2005.10.008  1
2006 Sehatpour P, Molholm S, Javitt DC, Foxe JJ. Spatiotemporal dynamics of human object recognition processing: an integrated high-density electrical mapping and functional imaging study of "closure" processes. Neuroimage. 29: 605-18. PMID 16168676 DOI: 10.1016/j.neuroimage.2005.07.049  1
2006 Wylie GR, Javitt DC, Foxe JJ. Jumping the gun: is effective preparation contingent upon anticipatory activation in task-relevant neural circuitry? Cerebral Cortex (New York, N.Y. : 1991). 16: 394-404. PMID 15917482 DOI: 10.1093/cercor/bhi118  1
2006 Javitt DC. Glutamate involvement in schizophrenia: Focus on N-methyl-D-aspartate receptors Primary Psychiatry. 13: 38-46.  1
2005 Butler PD, Javitt DC. Early-stage visual processing deficits in schizophrenia. Current Opinion in Psychiatry. 18: 151-7. PMID 16639168  1
2005 Neeman G, Blanaru M, Bloch B, Kremer I, Ermilov M, Javitt DC, Heresco-Levy U. Relation of plasma glycine, serine, and homocysteine levels to schizophrenia symptoms and medication type. The American Journal of Psychiatry. 162: 1738-40. PMID 16135636 DOI: 10.1176/appi.ajp.162.9.1738  1
2005 Ardekani BA, Bappal A, D'Angelo D, Ashtari M, Lencz T, Szeszko PR, Butler PD, Javitt DC, Lim KO, Hrabe J, Nierenberg J, Branch CA, Hoptman MJ. Brain morphometry using diffusion-weighted magnetic resonance imaging: application to schizophrenia. Neuroreport. 16: 1455-9. PMID 16110271 DOI: 10.1097/01.wnr.0000177001.27569.06  1
2005 Schechter I, Butler PD, Zemon VM, Revheim N, Saperstein AM, Jalbrzikowski M, Pasternak R, Silipo G, Javitt DC. Impairments in generation of early-stage transient visual evoked potentials to magno- and parvocellular-selective stimuli in schizophrenia. Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. 116: 2204-15. PMID 16055375 DOI: 10.1016/j.clinph.2005.06.013  1
2005 Leitman DI, Foxe JJ, Butler PD, Saperstein A, Revheim N, Javitt DC. Sensory contributions to impaired prosodic processing in schizophrenia. Biological Psychiatry. 58: 56-61. PMID 15992523 DOI: 10.1016/j.biopsych.2005.02.034  1
2005 Lakatos P, Pincze Z, Fu KM, Javitt DC, Karmos G, Schroeder CE. Timing of pure tone and noise-evoked responses in macaque auditory cortex. Neuroreport. 16: 933-7. PMID 15931064 DOI: 10.1097/00001756-200506210-00011  1
2005 Kim D, Zemon V, Saperstein A, Butler PD, Javitt DC. Dysfunction of early-stage visual processing in schizophrenia: harmonic analysis. Schizophrenia Research. 76: 55-65. PMID 15927798 DOI: 10.1016/j.schres.2004.10.011  1
2005 Butler PD, Zemon V, Schechter I, Saperstein AM, Hoptman MJ, Lim KO, Revheim N, Silipo G, Javitt DC. Early-stage visual processing and cortical amplification deficits in schizophrenia. Archives of General Psychiatry. 62: 495-504. PMID 15867102 DOI: 10.1001/archpsyc.62.5.495  1
2005 Heresco-Levy U, Javitt DC, Ebstein R, Vass A, Lichtenberg P, Bar G, Catinari S, Ermilov M. D-serine efficacy as add-on pharmacotherapy to risperidone and olanzapine for treatment-refractory schizophrenia. Biological Psychiatry. 57: 577-85. PMID 15780844 DOI: 10.1016/j.biopsych.2004.12.037  1
2005 Foxe JJ, Murray MM, Javitt DC. Filling-in in schizophrenia: a high-density electrical mapping and source-analysis investigation of illusory contour processing. Cerebral Cortex (New York, N.Y. : 1991). 15: 1914-27. PMID 15772373 DOI: 10.1093/cercor/bhi069  1
2005 Javitt DC, Hashim A, Sershen H. Modulation of striatal dopamine release by glycine transport inhibitors. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 30: 649-56. PMID 15688094 DOI: 10.1038/sj.npp.1300589  1
2005 Murray MM, Molholm S, Michel CM, Heslenfeld DJ, Ritter W, Javitt DC, Schroeder CE, Foxe JJ. Grabbing your ear: rapid auditory-somatosensory multisensory interactions in low-level sensory cortices are not constrained by stimulus alignment. Cerebral Cortex (New York, N.Y. : 1991). 15: 963-74. PMID 15537674 DOI: 10.1093/cercor/bhh197  1
2005 Molholm S, Martinez A, Ritter W, Javitt DC, Foxe JJ. The neural circuitry of pre-attentive auditory change-detection: an fMRI study of pitch and duration mismatch negativity generators. Cerebral Cortex (New York, N.Y. : 1991). 15: 545-51. PMID 15342438 DOI: 10.1093/cercor/bhh155  1
2005 Javitt DC, Duncan L, Balla A, Sershen H. Inhibition of system A-mediated glycine transport in cortical synaptosomes by therapeutic concentrations of clozapine: implications for mechanisms of action. Molecular Psychiatry. 10: 275-87. PMID 15278098 DOI: 10.1038/sj.mp.4001552  1
2004 Hoptman MJ, Ardekani BA, Butler PD, Nierenberg J, Javitt DC, Lim KO. DTI and impulsivity in schizophrenia: a first voxelwise correlational analysis. Neuroreport. 15: 2467-70. PMID 15538176 DOI: 10.1097/00001756-200411150-00007  1
2004 Kremer I, Vass A, Gorelik I, Bar G, Blanaru M, Javitt DC, Heresco-Levy U. Placebo-controlled trial of lamotrigine added to conventional and atypical antipsychotics in schizophrenia. Biological Psychiatry. 56: 441-6. PMID 15364042 DOI: 10.1016/j.biopsych.2004.06.029  1
2004 Murray MM, Foxe DM, Javitt DC, Foxe JJ. Setting boundaries: brain dynamics of modal and amodal illusory shape completion in humans. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 6898-903. PMID 15295024 DOI: 10.1523/JNEUROSCI.1996-04.2004  1
2004 Javitt DC. Glutamate as a therapeutic target in psychiatric disorders. Molecular Psychiatry. 9: 984-97, 979. PMID 15278097 DOI: 10.1038/sj.mp.4001551  1
2004 Hester RL, Murphy K, Foxe JJ, Foxe DM, Javitt DC, Garavan H. Predicting success: patterns of cortical activation and deactivation prior to response inhibition. Journal of Cognitive Neuroscience. 16: 776-85. PMID 15200705 DOI: 10.1162/089892904970726  1
2004 Fassbender C, Murphy K, Foxe JJ, Wylie GR, Javitt DC, Robertson IH, Garavan H. A topography of executive functions and their interactions revealed by functional magnetic resonance imaging. Brain Research. Cognitive Brain Research. 20: 132-43. PMID 15183386 DOI: 10.1016/j.cogbrainres.2004.02.007  1
2004 Kelly AM, Hester R, Murphy K, Javitt DC, Foxe JJ, Garavan H. Prefrontal-subcortical dissociations underlying inhibitory control revealed by event-related fMRI. The European Journal of Neuroscience. 19: 3105-12. PMID 15182319 DOI: 10.1111/j.0953-816X.2004.03429.x  1
2004 Xie S, Aspromonte J, Balla A, Sershen H, Javitt DC, Cooper TB. Sensitive and simple gas chromatographic-mass spectrometric determination for amphetamine in microdialysate and ultrafiltrate samples. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 805: 27-31. PMID 15113536 DOI: 10.1016/j.jchromb.2004.02.001  1
2004 Wylie GR, Javitt DC, Foxe JJ. The role of response requirements in task switching: dissolving the residue. Neuroreport. 15: 1079-87. PMID 15076739 DOI: 10.1097/00001756-200404290-00030  1
2004 Heresco-Levy U, Javitt DC. Comparative effects of glycine and D-cycloserine on persistent negative symptoms in schizophrenia: a retrospective analysis. Schizophrenia Research. 66: 89-96. PMID 15061240 DOI: 10.1016/S0920-9964(03)00129-4  1
2004 Wylie GR, Javitt DC, Foxe JJ. Don't think of a white bear: an fMRI investigation of the effects of sequential instructional sets on cortical activity in a task-switching paradigm. Human Brain Mapping. 21: 279-97. PMID 15038009 DOI: 10.1002/hbm.20003  1
2004 Shoham S, Mazeh H, Javitt DC, Heresco-Levy U. Glycine and D-cycloserine attenuate vacuous chewing movements in a rat model of tardive dyskinesia. Brain Research. 1004: 142-7. PMID 15033429 DOI: 10.1016/j.brainres.2004.01.022  1
2004 Molholm S, Ritter W, Javitt DC, Foxe JJ. Multisensory visual-auditory object recognition in humans: a high-density electrical mapping study. Cerebral Cortex (New York, N.Y. : 1991). 14: 452-65. PMID 15028649 DOI: 10.1093/cercor/bhh007  1
2004 Heresco-Levy U, Ermilov M, Lichtenberg P, Bar G, Javitt DC. High-dose glycine added to olanzapine and risperidone for the treatment of schizophrenia. Biological Psychiatry. 55: 165-71. PMID 14732596 DOI: 10.1016/S0006-3223(03)00707-8  1
2004 Javitt DC, Coyle JT. Decoding schizophrenia. Scientific American. 290: 48-55. PMID 14682038  1
2004 Javitt DC, Balla A, Burch S, Suckow R, Xie S, Sershen H. Reversal of phencyclidine-induced dopaminergic dysregulation by N-methyl-D-aspartate receptor/glycine-site agonists. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 29: 300-7. PMID 14560321 DOI: 10.1038/sj.npp.1300313  1
2004 Javitt DC. Glutamate receptors as therapeutic targets Molecular Psychiatry. 9: 979. DOI: 10.1038/sj.mp.4001602  1
2003 Wylie GR, Javitt DC, Foxe JJ. Task switching: a high-density electrical mapping study. Neuroimage. 20: 2322-42. PMID 14683733 DOI: 10.1016/j.neuroimage.2003.08.010  1
2003 Schechter I, Butler PD, Silipo G, Zemon V, Javitt DC. Magnocellular and parvocellular contributions to backward masking dysfunction in schizophrenia. Schizophrenia Research. 64: 91-101. PMID 14613674 DOI: 10.1016/S0920-9964(03)00008-2  1
2003 Ardekani BA, Nierenberg J, Hoptman MJ, Javitt DC, Lim KO. MRI study of white matter diffusion anisotropy in schizophrenia. Neuroreport. 14: 2025-9. PMID 14600491 DOI: 10.1097/01.wnr.0000093290.85057.0d  1
2003 Foxe JJ, McCourt ME, Javitt DC. Right hemisphere control of visuospatial attention: line-bisection judgments evaluated with high-density electrical mapping and source analysis. Neuroimage. 19: 710-26. PMID 12880801 DOI: 10.1016/S1053-8119(03)00057-0  1
2003 Linn GS, Negi SS, Gerum SV, Javitt DC. Reversal of phencyclidine-induced prepulse inhibition deficits by clozapine in monkeys. Psychopharmacology. 169: 234-9. PMID 12845408 DOI: 10.1007/s00213-003-1533-8  1
2003 Dias EC, Foxe JJ, Javitt DC. Changing plans: a high density electrical mapping study of cortical control. Cerebral Cortex (New York, N.Y. : 1991). 13: 701-15. PMID 12816885 DOI: 10.1093/cercor/13.7.701  1
2003 Wylie GR, Javitt DC, Foxe JJ. Cognitive control processes during an anticipated switch of task. The European Journal of Neuroscience. 17: 667-72. PMID 12581185 DOI: 10.1046/j.1460-9568.2003.02474.x  1
2003 Balla A, Sershen H, Serra M, Koneru R, Javitt DC. Subchronic continuous phencyclidine administration potentiates amphetamine-induced frontal cortex dopamine release. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 28: 34-44. PMID 12496938 DOI: 10.1038/sj.npp.1300019  1
2003 Butler PD, DeSanti LA, Maddox J, Harkavy-Friedman JM, Amador XF, Goetz RR, Javitt DC, Gorman JM. Visual backward-masking deficits in schizophrenia: relationship to visual pathway function and symptomatology. Schizophrenia Research. 59: 199-209. PMID 12414076 DOI: 10.1016/S0920-9964(01)00341-3  1
2003 Javitt DC. Peeling the onion: NMDA dysfunction as a unifying model in schizophrenia Behavioral and Brain Sciences. 26: 93-94. DOI: 10.1017/S0140525X0333002X  1
2002 Heresco-Levy U, Kremer I, Javitt DC, Goichman R, Reshef A, Blanaru M, Cohen T. Pilot-controlled trial of D-cycloserine for the treatment of post-traumatic stress disorder. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 5: 301-7. PMID 12466030 DOI: 10.1017/S1461145702003061  1
2002 Doniger GM, Foxe JJ, Murray MM, Higgins BA, Javitt DC. Impaired visual object recognition and dorsal/ventral stream interaction in schizophrenia. Archives of General Psychiatry. 59: 1011-20. PMID 12418934 DOI: 10.1001/archpsyc.59.11.1011  1
2002 Cahn W, Hulshoff Pol HE, Lems EB, van Haren NE, Schnack HG, van der Linden JA, Schothorst PF, van Engeland H, Kahn RS. Brain volume changes in first-episode schizophrenia: a 1-year follow-up study. Archives of General Psychiatry. 59: 1002-10. PMID 12418933 DOI: 10.1001/archpsyc.59.11.1002  1
2002 Javitt DC, Cienfuegos A, Miniati M, Silipo G, Levine J, Allingham BH, Robinson J. A naturalistic study of risperidone treatment outcome using prognosis-adjusted discharge rates in New York State inpatients. The Journal of Clinical Psychiatry. 63: 585-90. PMID 12143914  0.72
2002 Foxe JJ, Wylie GR, Martinez A, Schroeder CE, Javitt DC, Guilfoyle D, Ritter W, Murray MM. Auditory-somatosensory multisensory processing in auditory association cortex: an fMRI study. Journal of Neurophysiology. 88: 540-3. PMID 12091578  1
2002 Murray MM, Wylie GR, Higgins BA, Javitt DC, Schroeder CE, Foxe JJ. The spatiotemporal dynamics of illusory contour processing: combined high-density electrical mapping, source analysis, and functional magnetic resonance imaging. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 22: 5055-73. PMID 12077201  1
2002 Molholm S, Ritter W, Murray MM, Javitt DC, Schroeder CE, Foxe JJ. Multisensory auditory-visual interactions during early sensory processing in humans: a high-density electrical mapping study. Brain Research. Cognitive Brain Research. 14: 115-28. PMID 12063135 DOI: 10.1016/S0926-6410(02)00066-6  1
2002 Heresco-Levy U, Ermilov M, Shimoni J, Shapira B, Silipo G, Javitt DC. Placebo-controlled trial of D-cycloserine added to conventional neuroleptics, olanzapine, or risperidone in schizophrenia. The American Journal of Psychiatry. 159: 480-2. PMID 11870017  0.72
2001 Javitt DC, Silipo G, Cienfuegos A, Shelley AM, Bark N, Park M, Lindenmayer JP, Suckow R, Zukin SR. Adjunctive high-dose glycine in the treatment of schizophrenia. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 4: 385-91. PMID 11806864 DOI: doi:10.1017/S1461145701002590  0.72
2001 Foxe JJ, Doniger GM, Javitt DC. Early visual processing deficits in schizophrenia: impaired P1 generation revealed by high-density electrical mapping. Neuroreport. 12: 3815-20. PMID 11726801  1
2001 Doniger GM, Silipo G, Rabinowicz EF, Snodgrass JG, Javitt DC. Impaired sensory processing as a basis for object-recognition deficits in schizophrenia. The American Journal of Psychiatry. 158: 1818-26. PMID 11691687 DOI: 10.1176/appi.ajp.158.11.1818  1
2001 Javitt DC, Lindsley RW. Effects of phencyclidine on prepulse inhibition of acoustic startle response in the macaque. Psychopharmacology. 156: 165-8. PMID 11549218  0.48
2001 Fu KM, Foxe JJ, Murray MM, Higgins BA, Javitt DC, Schroeder CE. Attention-dependent suppression of distracter visual input can be cross-modally cued as indexed by anticipatory parieto-occipital alpha-band oscillations. Brain Research. Cognitive Brain Research. 12: 145-52. PMID 11489617 DOI: 10.1016/S0926-6410(01)00034-9  1
2001 Butler PD, Schechter I, Zemon V, Schwartz SG, Greenstein VC, Gordon J, Schroeder CE, Javitt DC. Dysfunction of early-stage visual processing in schizophrenia. The American Journal of Psychiatry. 158: 1126-33. PMID 11431235 DOI: 10.1176/appi.ajp.158.7.1126  1
2001 Balla A, Koneru R, Smiley J, Sershen H, Javitt DC. Continuous phencyclidine treatment induces schizophrenia-like hyperreactivity of striatal dopamine release. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 25: 157-64. PMID 11425499 DOI: 10.1016/S0893-133X(01)00230-5  1
2001 Murray MM, Foxe JJ, Higgins BA, Javitt DC, Schroeder CE. Visuo-spatial neural response interactions in early cortical processing during a simple reaction time task: a high-density electrical mapping study. Neuropsychologia. 39: 828-44. PMID 11369406 DOI: 10.1016/S0028-3932(01)00004-5  1
2001 Shoham S, Javitt DC, Heresco-Levy U. Chronic high-dose glycine nutrition: effects on rat brain cell morphology. Biological Psychiatry. 49: 876-85. PMID 11343684 DOI: 10.1016/S0006-3223(00)01046-5  1
2001 Schroeder CE, Lindsley RW, Specht C, Marcovici A, Smiley JF, Javitt DC. Somatosensory input to auditory association cortex in the macaque monkey. Journal of Neurophysiology. 85: 1322-7. PMID 11248001  1
2001 Linn GS, Javitt DC. Phencyclidine (PCP)-induced deficits of prepulse inhibition in monkeys. Neuroreport. 12: 117-20. PMID 11201070  0.4
2001 Doniger GM, Foxe JJ, Schroeder CE, Murray MM, Higgins BA, Javitt DC. Visual perceptual learning in human object recognition areas: a repetition priming study using high-density electrical mapping. Neuroimage. 13: 305-13. PMID 11162271 DOI: 10.1006/nimg.2000.0684  1
2000 Javitt DC, Heresco-Levy U. Are glycine sites saturated in vivo? Archives of General Psychiatry. 57: 1181-3. PMID 11115334  1
2000 Rabinowicz EF, Silipo G, Goldman R, Javitt DC. Auditory sensory dysfunction in schizophrenia: imprecision or distractibility? Archives of General Psychiatry. 57: 1149-55. PMID 11115328  0.72
2000 Umbricht D, Schmid L, Koller R, Vollenweider FX, Hell D, Javitt DC. Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers: implications for models of cognitive deficits in schizophrenia. Archives of General Psychiatry. 57: 1139-47. PMID 11115327  1
2000 Javitt DC, Shelley AM, Silipo G, Lieberman JA. Deficits in auditory and visual context-dependent processing in schizophrenia: defining the pattern. Archives of General Psychiatry. 57: 1131-7. PMID 11115326  1
2000 Javitt DC, Shelley A, Ritter W. Associated deficits in mismatch negativity generation and tone matching in schizophrenia. Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. 111: 1733-7. PMID 11018486 DOI: 10.1016/S1388-2457(00)00377-1  1
2000 Foxe JJ, Morocz IA, Murray MM, Higgins BA, Javitt DC, Schroeder CE. Multisensory auditory-somatosensory interactions in early cortical processing revealed by high-density electrical mapping. Brain Research. Cognitive Brain Research. 10: 77-83. PMID 10978694 DOI: 10.1016/S0926-6410(00)00024-0  1
2000 Doniger GM, Foxe JJ, Murray MM, Higgins BA, Snodgrass JG, Schroeder CE, Javitt DC. Activation timecourse of ventral visual stream object-recognition areas: high density electrical mapping of perceptual closure processes. Journal of Cognitive Neuroscience. 12: 615-21. PMID 10936914  1
2000 Javitt DC, Jayachandra M, Lindsley RW, Specht CM, Schroeder CE. Schizophrenia-like deficits in auditory P1 and N1 refractoriness induced by the psychomimetic agent phencyclidine (PCP). Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. 111: 833-6. PMID 10802454 DOI: 10.1016/S1388-2457(99)00313-2  1
2000 Smiley JF, McGinnis JP, Javitt DC. Nitric oxide synthase interneurons in the monkey cerebral cortex are subsets of the somatostatin, neuropeptide Y, and calbindin cells. Brain Research. 863: 205-12. PMID 10773208 DOI: 10.1016/S0006-8993(00)02136-3  1
1999 Shoham S, Javitt DC, Heresco-Levy U. High dose glycine nutrition affects glial cell morphology in rat hippocampus and cerebellum. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 2: 35-40. PMID 11281969 DOI: 10.1017/S1461145799001285  1
1999 Javitt DC, Liederman E, Cienfuegos A, Shelley AM. Panmodal processing imprecision as a basis for dysfunction of transient memory storage systems in schizophrenia. Schizophrenia Bulletin. 25: 763-75. PMID 10667746  0.48
1999 Linn GS, O'Keeffe RT, Schroeder CE, Lifshitz K, Javitt DC. Behavioral effects of chronic phencyclidine in monkeys. Neuroreport. 10: 2789-93. PMID 10511441  1
1999 Shelley AM, Silipo G, Javitt DC. Diminished responsiveness of ERPs in schizophrenic subjects to changes in auditory stimulation parameters: implications for theories of cortical dysfunction. Schizophrenia Research. 37: 65-79. PMID 10227109  0.72
1999 March L, Cienfuegos A, Goldbloom L, Ritter W, Cowan N, Javitt DC. Normal time course of auditory recognition in schizophrenia, despite impaired precision of the auditory sensory ("echoic") memory code. Journal of Abnormal Psychology. 108: 69-75. PMID 10066994 DOI: 10.1037//0021-843X.108.1.69  1
1999 Cienfuegos A, March L, Shelley AM, Javitt DC. Impaired categorical perception of synthetic speech sounds in schizophrenia. Biological Psychiatry. 45: 82-8. PMID 9894579  0.48
1999 Heresco-Levy U, Javitt DC, Ermilov M, Mordel C, Silipo G, Lichtenstein M. Efficacy of high-dose glycine in the treatment of enduring negative symptoms of schizophrenia. Archives of General Psychiatry. 56: 29-36. PMID 9892253  0.72
1998 Heresco-Levy U, Javitt DC, Ermilov M, Silipo G, Shimoni J. Double-blind, placebo-controlled, crossover trial of D-cycloserine adjuvant therapy for treatment-resistant schizophrenia. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 1: 131-135. PMID 11281957 DOI: 10.1017/S1461145798001242  0.72
1998 Heresco-Levy U, Javitt DC. The role of N-methyl-D-aspartate (NMDA) receptor-mediated neurotransmission in the pathophysiology and therapeutics of psychiatric syndromes. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 8: 141-52. PMID 9619693  0.52
1998 Javitt DC, Grochowski S, Shelley AM, Ritter W. Impaired mismatch negativity (MMN) generation in schizophrenia as a function of stimulus deviance, probability, and interstimulus/interdeviant interval. Electroencephalography and Clinical Neurophysiology. 108: 143-53. PMID 9566627  1
1997 Heresco-Levy U, Greenberg D, Lerer B, Javitt DC, Brown WA. Serum neuroleptic levels during reduced dose fluphenazine decanoate maintenance therapy. The Israel Journal of Psychiatry and Related Sciences. 34: 281-9. PMID 9409085  0.52
1997 Winsberg BG, Javitt DC, Silipo GS. Electrophysiological indices of information processing in methylphenidate responders. Biological Psychiatry. 42: 434-45. PMID 9285079  0.52
1997 Schroeder CE, Javitt DC, Steinschneider M, Mehta AD, Givre SJ, Vaughan HG, Arezzo JC. N-methyl-D-aspartate enhancement of phasic responses in primate neocortex. Experimental Brain Research. 114: 271-8. PMID 9166916  1
1997 Javitt DC, Strous RD, Grochowski S, Ritter W, Cowan N. Impaired precision, but normal retention, of auditory sensory ("echoic") memory information in schizophrenia. Journal of Abnormal Psychology. 106: 315-24. PMID 9131851 DOI: 10.1037//0021-843X.106.2.315  1
1996 Heresco-Levy U, Silipo G, Javitt DC. Glycinergic augmentation of NMDA receptor-mediated neurotransmission in the treatment of schizophrenia. Psychopharmacology Bulletin. 32: 731-40. PMID 8993096  0.72
1996 Heresco-Levy U, Javitt DC, Ermilov M, Mordel C, Horowitz A, Kelly D. Double-blind, placebo-controlled, crossover trial of glycine adjuvant therapy for treatment-resistant schizophrenia. The British Journal of Psychiatry : the Journal of Mental Science. 169: 610-7. PMID 8932891  0.52
1996 Negrón AE, Leiderman EA, Parkadavil M, Cienfuegos A, Javitt DC. A naturalistic outcome study of risperidone treatment among hospital patients. Psychiatric Services (Washington, D.C.). 47: 1118-20. PMID 8890343  0.32
1996 Javitt DC, Steinschneider M, Schroeder CE, Arezzo JC. Role of cortical N-methyl-D-aspartate receptors in auditory sensory memory and mismatch negativity generation: implications for schizophrenia. Proceedings of the National Academy of Sciences of the United States of America. 93: 11962-7. PMID 8876245 DOI: 10.1073/pnas.93.21.11962  1
1996 Leiderman E, Zylberman I, Zukin SR, Cooper TB, Javitt DC. Preliminary investigation of high-dose oral glycine on serum levels and negative symptoms in schizophrenia: an open-label trial. Biological Psychiatry. 39: 213-5. PMID 8837983 DOI: 10.1016/0006-3223(95)00585-4  1
1996 Shelley AM, Grochowski S, Lieberman JA, Javitt DC. Premature disinhibition of P3 generation in schizophrenia. Biological Psychiatry. 39: 714-9. PMID 8731459 DOI: 10.1016/0006-3223(95)00222-7  1
1996 Strous RD, Javitt DC. The N-methyl-D-aspartate receptor and schizophrenia. Israel Journal of Medical Sciences. 32: 275-81. PMID 8641863  0.44
1995 Ritter W, Deacon D, Gomes H, Javitt DC, Vaughan HG. The mismatch negativity of event-related potentials as a probe of transient auditory memory: a review. Ear and Hearing. 16: 52-67. PMID 7774769  1
1995 Schroeder CE, Steinschneider M, Javitt DC, Tenke CE, Givre SJ, Mehta AD, Simpson GV, Arezzo JC, Vaughan HG. Localization of ERP generators and identification of underlying neural processes. Electroencephalography and Clinical Neurophysiology. Supplement. 44: 55-75. PMID 7649056  1
1995 Javitt DC, Schroeder CE, Steinschneider M, Arezzo JC, Ritter W, Vaughan HG. Cognitive event-related potentials in human and non-human primates: implications for the PCP/NMDA model of schizophrenia. Electroencephalography and Clinical Neurophysiology. Supplement. 44: 161-75. PMID 7649018  1
1995 Zylberman I, Javitt DC, Zukin SR. Pharmacological augmentation of NMDA receptor function for treatment of schizophrenia. Annals of the New York Academy of Sciences. 757: 487-91. PMID 7611706 DOI: 10.1111/j.1749-6632.1995.tb17508.x  1
1995 Javitt DC, Doneshka P, Grochowski S, Ritter W. Impaired mismatch negativity generation reflects widespread dysfunction of working memory in schizophrenia. Archives of General Psychiatry. 52: 550-8. PMID 7598631 DOI: 10.1001/archpsyc.1995.03950190032005  1
1995 Strous RD, Cowan N, Ritter W, Javitt DC. Auditory sensory ("echoic") memory dysfunction in schizophrenia. The American Journal of Psychiatry. 152: 1517-9. PMID 7573594  1
1994 Javitt DC, Zylberman I, Zukin SR, Heresco-Levy U, Lindenmayer JP. Amelioration of negative symptoms in schizophrenia by glycine. The American Journal of Psychiatry. 151: 1234-6. PMID 8037263  1
1994 Javitt DC, Frusciante MJ, Zukin SR. Activation-related and activation-independent effects of polyamines on phencyclidine receptor binding within the N-methyl-D-aspartate receptor complex. The Journal of Pharmacology and Experimental Therapeutics. 270: 604-13. PMID 7915316  1
1994 Javitt DC, Steinschneider M, Schroeder CE, Vaughan HG, Arezzo JC. Detection of stimulus deviance within primate primary auditory cortex: intracortical mechanisms of mismatch negativity (MMN) generation. Brain Research. 667: 192-200. PMID 7697356 DOI: 10.1016/0006-8993(94)91496-6  1
1993 Javitt DC, Doneshka P, Zylberman I, Ritter W, Vaughan HG. Impairment of early cortical processing in schizophrenia: an event-related potential confirmation study. Biological Psychiatry. 33: 513-9. PMID 8513035 DOI: 10.1016/0006-3223(93)90005-X  1
1993 Winsberg BG, Javitt DC, Silipo GS, Doneshka P. Mismatch negativity in hyperactive children: effects of methylphenidate. Psychopharmacology Bulletin. 29: 229-33. PMID 8290670  0.52
1993 Zukin SR, Javitt DC. Phencyclidine receptor binding as a probe of NMDA receptor functioning: implications for drug abuse research. Nida Research Monograph. 133: 1-12. PMID 8232509  1
1992 Javitt DC, Schroeder CE, Steinschneider M, Arezzo JC, Vaughan HG. Demonstration of mismatch negativity in the monkey. Electroencephalography and Clinical Neurophysiology. 83: 87-90. PMID 1376671 DOI: 10.1016/0013-4694(92)90137-7  1
1992 Steinschneider M, Tenke CE, Schroeder CE, Javitt DC, Simpson GV, Arezzo JC, Vaughan HG. Cellular generators of the cortical auditory evoked potential initial component. Electroencephalography and Clinical Neurophysiology. 84: 196-200. PMID 1372236 DOI: 10.1016/0168-5597(92)90026-8  1
1991 Nussenzveig IZ, Sircar R, Wong ML, Frusciante MJ, Javitt DC, Zukin SR. Polyamine effects upon N-methyl-D-aspartate receptor functioning: differential alteration by glutamate and glycine site antagonists. Brain Research. 561: 285-91. PMID 1686987 DOI: 10.1016/0006-8993(91)91606-2  1
1991 Javitt DC, Zukin SR. Recent advances in the phencyclidine model of schizophrenia. The American Journal of Psychiatry. 148: 1301-8. PMID 1654746  1
1990 Javitt DC, Frusciante MJ, Zukin SR. Rat brain N-methyl-D-aspartate receptors require multiple molecules of agonist for activation. Molecular Pharmacology. 37: 603-7. PMID 2160056  1
1990 Javitt DC, Zukin SR. The role of excitatory amino acids in neuropsychiatric illness. The Journal of Neuropsychiatry and Clinical Neurosciences. 2: 44-52. PMID 1983773  1
1989 Zukin SR, Javitt DC. Mechanisms of phencyclidine (PCP)-n-methyl-d-aspartate (NMDA) receptor interaction: implications for drug abuse research. Nida Research Monograph. 95: 247-54. PMID 2561829  1
1989 Javitt DC, Zukin SR. Interaction of [3H]MK-801 with multiple states of the N-methyl-D-aspartate receptor complex of rat brain. Proceedings of the National Academy of Sciences of the United States of America. 86: 740-4. PMID 2536176  1
1989 Javitt DC, Zukin SR. Biexponential kinetics of [3H]MK-801 binding: evidence for access to closed and open N-methyl-D-aspartate receptor channels. Molecular Pharmacology. 35: 387-93. PMID 2468076  1
1988 Javitt DC, Zukin SR. Modulation of phencyclidine receptors by excitatory amino acid receptor ligands. Psychopharmacology Bulletin. 24: 444-9. PMID 2856419  1
1987 Javitt DC, Jotkowitz A, Sircar R, Zukin SR. Non-competitive regulation of phencyclidine/sigma-receptors by the N-methyl-D-aspartate receptor antagonist D-(-)-2-amino-5-phosphonovaleric acid. Neuroscience Letters. 78: 193-8. PMID 2888059 DOI: 10.1016/0304-3940(87)90632-X  1
Show low-probability matches.